Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Ment Health Policy Econ. 2019 Sep 1;22(3):95–108.

Table 5:

Association between Use of SEE for Employment Only and Employment in Subsequent Quarter

Q2 Q3 Q4
Unadj Adj Without those who
used SEE for
education
Unadj Adj Without those who
used SEE for
education
Unadj Adj Without those
who used SEE
for education
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
OR
95% CI
SEE use for employment only, previous qtr 2.891.89–4.43 2.741.64–4.56 4.182.11–8.28 1.09 0.66–1.82 0.72 0.37–1.39 0.95 0.44–2.09 1.08 0.61–1.90 1.06 0.55–2.06 1.28 0.58–2.81
Employment status, baseline -- 7.573.47–16.51 8.903.33–23.79 -- 10.683.94–28.99 14.834.11–53.47 -- 8.142.53–26.16 23.133.63–147.34
GAF symptoms, baseline -- 1.01 0.99–1.02 1.00 0.98–1.03 -- 0.98* 0.96–1.00 0.970.94–0.997 -- 1.01 0.99–1.02 1.02 0.99–1.05
Program site -- 1.00 0.95–1.05 1.00 0.94–1.07 -- 1.06 0.99–1.14 1.06 0.96–1.17 -- 1.02 0.94–1.10 0.98 0.89–1.08
Age -- 1.03 0.95–1.13 1.04 0.92–1.17 -- 0.96 0.87–1.07 0.92 0.79–1.06 -- 1.06 0.94–1.19 0.99 0.85–1.14
Male (ref: not male) -- 0.560.33–0.95 0.52 0.24–1.15 -- 0.520.27–0.99 0.39* 0.15–1.03 -- 0.52* 0.26–1.04 0.84 0.32–2.21
Race/ethnicity (ref: white non-Hispanic)
Black non-Hispanic -- 0.63 0.36–1.12 0.59 0.27–1.29 -- 0.74 0.38–1.44 0.48 0.19–1.23 -- 0.68 0.34–1.37 0.61 0.23–1.62
Hispanic -- 1.36 0.75–2.48 0.93 0.39–2.24 -- 1.36 0.66–2.80 0.78 0.28–2.16 -- 1.07 0.48–2.40 0.72 0.22–2.32
Other non-Hispanic -- 0.56 0.24–1.27 0.93 0.29–3.03 -- 0.48 0.18–1.29 0.29* 0.07–1.17 -- 0.39 0.13–1.21 0.140.03–0.75
Educational attainment at baseline (ref: less than high school)
High school/GED -- 1.61 0.80–3.21 0.90 0.32–2.56 -- 1.98 0.87–4.54 1.62 0.48–5.42 -- 1.43 0.59–3.44 2.06 0.59–7.18
Some college -- 2.121.16–3.88 1.54 0.60–3.93 -- 2.811.36–5.84 1.86 0.60–5.81 -- 1.79 0.83–3.86 2.01 0.67–5.99
College or more -- 2.05 0.73–5.73 1.02 0.26–3.92 -- 10.132.65–38.70 9.761.62–58.96 -- 2.83 0.74–10.91 4.94* 0.95–25.62
Time from onset to admission -- 0.960.92–0.99 0.930.88–0.98 -- 0.96 0.92–1.01 0.96 0.91–1.03 -- 0.940.90–0.99 0.95 0.88–1.01
Antipsychotic Medication adherence at baseline (ref: not adherent or adherence unknown)
Adherent -- 1.36 0.78–2.39 1.33 0.61–2.92 -- 1.991.00–3.94 2.49* 0.96–6.46 -- 0.72 0.35–1.50 0.63 0.24–1.63
No medications prescribed -- 2.11 0.78–5.71 2.17 0.52–9.04 -- 0.83 0.24–2.85 1.48 0.30–7.38 -- 0.79 0.22–2.78 0.38 0.06–2.34
Used substances (baseline) -- 1.45 0.92–2.29 1.931.01–3.68 -- 2.641.55–4.51 2.451.12–5.36 -- 1.42 0.80–2.52 2.03* 0.93–4.44
Live with parents(baseline) -- 0.93 0.47–1.86 0.90 0.37–2.20 -- 0.390.16–0.92 0.69 0.21–2.25 -- 0.350.14–0.91 0.62 0.18–2.14
Legal history(baseline) -- 2.661.16–6.11 0.74 0.23–2.42 -- 2.03 0.83–4.96 1.47 0.38–5.71 -- 2.53* 0.95–6.68 0.80 0.19–3.25

Bold indicates significance (p<0.05)

*

indicates approaching significance (p<0.10).